🇺🇸 FDA
Patent

US 10143751

Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof

granted A61KA61K41/0057A61K47/32

Quick answer

US patent 10143751 (Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof) held by SANOCHEMIA PHARMAZEUTIKA AG expires Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANOCHEMIA PHARMAZEUTIKA AG
Grant date
Tue Dec 04 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K41/0057, A61K47/32, A61K47/58, A61K47/60